HDAC6 Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation in Renal Epithelial Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Liu, Wei ^a,b,c   Fan, Lucy X ^a,b   Zhou, Xia ^a,b   Sweeney, William E ^a,b   Avner, Ellis D ^a,b   Li, Xiaogang ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital of Wisconsin ^*  (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE DEACETYLASE 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRICHOSTATIN A; TUBACIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE; GENE MUTATION; HISTONE ACETYLATION; KIDNEY EPITHELIUM; KNOCKOUT MOUSE; MICROTUBULE; MOUSE; NONHUMAN; PKD1 GENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; UPREGULATION;

EID: 84869008969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049418     Document Type: Article

References (28)

1. Harris PC, Torres VE, (2009) Polycystic kidney disease. Annu Rev Med 60: 321-337.
2. Torres VE, Harris PC, (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76: 149-168.
3. Wilson PD, (2004) Polycystic kidney disease. N Engl J Med 350: 151-164.
4. Melenhorst WB, Mulder GM, Xi Q, Hoenderop JG, Kimura K, et al. (2008) Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension 52: 987-993.
5. Du J, Wilson PD, (1995) Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269: C487-495.
6. Orellana SA, Sweeney WE, Neff CD, Avner ED, (1995) Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47: 490-499.
7. Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, et al. (1998) Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 101: 935-939.
8. Sweeney WE Jr, Avner ED, (1998) Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387-394.
9. Li X, (2011) Epigenetics and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 1812: 1213-1218.
10. Zeng F, Singh AB, Harris RC, (2009) The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 315: 602-610.
11. Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED, (2000) Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 57: 33-40.
12. Nauta J, Sweeney WE, Rutledge JC, Avner ED, (1995) Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr Res 37: 755-763.
13. Sweeney WE Jr, Avner ED, (2006) Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 326: 671-685.
14. Wang Z, Zhang L, Yeung TK, Chen X, (1999) Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol Biol Cell 10: 1621-1636.
15. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, et al. (2003) EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64: 1573-1579.
16. Gao YS, Hubbert CC, Yao TP, (2010) The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation. J Biol Chem 285: 11219-11226.
17. Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, et al. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 27: 3571-3583.
18. Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, et al. (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16: 2166-2172.
19. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, et al. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417: 455-458.
20. Deribe YL, Wild P, Chandrashaker A, Curak J, Schmidt MH, et al. (2009) Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal 2: ra84.
21. Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, et al. (2007) Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol 27: 8637-8647.
22. Kamemura K, Ito A, Shimazu T, Matsuyama A, Maeda S, et al. (2008) Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells. Biochem Biophys Res Commun 374: 84-89.
23. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN, van de Wal A, et al. (2004) Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 13: 3069-3077.
24. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, et al. (2002) In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. Embo J 21: 6820-6831.
25. Xia S, Li X, Johnson T, Seidel C, Wallace DP, et al. (2010) Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts. Development 137: 1075-1084.
26. Fan LX, Li X, Magenheimer B, Calvet JP, (2012) Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. Kidney Int 81: 76-85.
27. Li X, Magenheimer BS, Xia S, Johnson T, Wallace DP, et al. (2008) A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 14: 863-868.
28. Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, et al. (2008) Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet 17: 1505-1516.